ID

38775

Description

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM); ODM derived from: https://clinicaltrials.gov/show/NCT01733758

Link

https://clinicaltrials.gov/show/NCT01733758

Keywords

Versions (1)
  1. 11/3/19 11/3/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 3, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 2 NCT01733758

English

Eligibility Diabetes Mellitus, Type 2 NCT01733758

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with diagnosis of type 2 diabetes mellitus, treated with diet and exercise or a stable dose of 1 oad at screening
Description

Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Antidiabetics Oral Quantity | Antidiabetics Dose Stable

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
UMLS CUI [4,1]
C0935929
UMLS CUI [4,2]
C1527415
UMLS CUI [4,3]
C1265611
UMLS CUI [5,1]
C0935929
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
body mass index (bmi) 17 to 40 kg/ m^2 inclusive
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
subjects who are oad naïve, hba1c between 7.0% and 10.0% at screening and at visit 2; for subjects who enter the study with 1 oad, hba1c between 6.5% and 9.5% at screening and hba1c between 7.0% and 10.0% at visit 2
Description

Antidiabetics Oral Absent | Hemoglobin A1c measurement | Antidiabetics Oral Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0332197
UMLS CUI [2]
C0474680
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C1265611
creatinine clearance >30 ml/min (calculated using the cockcroft-gault formula)
Description

Estimation of creatinine clearance by Cockcroft-Gault formula

Data type

boolean

Alias
UMLS CUI [1]
C2711451
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes mellitus •female subject is pregnant, lactating, or <6 weeks postpartum•
Description

Diabetes Mellitus, Insulin-Dependent | Pregnancy | Breast Feeding | Postpartum Period

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0086839
clinically significant cardiovascular and/or cerebrovascular disease
Description

Cardiovascular Disease | Cerebrovascular Disorder

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0007820
current ongoing symptomatic biliary disease, clinical signs or symptoms of pancreatitis, or a history of chronic or acute pancreatitis, as determined by the investigator
Description

Gall Bladder Disease Symptomatic | Sign or Symptom Pancreatitis | Pancreatitis, Chronic | Pancreatitis

Data type

boolean

Alias
UMLS CUI [1,1]
C0016977
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C3540840
UMLS CUI [2,2]
C0030305
UMLS CUI [3]
C0149521
UMLS CUI [4]
C0030305
serum amylase >=3 ×uln and/or serum lipase >=2 × uln and/or subject is experiencing any symptoms possibly related to pancreatitis
Description

Serum amylase raised | Serum lipase raised | Symptoms Relationship Pancreatitis

Data type

boolean

Alias
UMLS CUI [1]
C0476327
UMLS CUI [2]
C3670924
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C0439849
UMLS CUI [3,3]
C0030305
prior use of a tzd or glp-1r agonist within 4 months before screening
Description

Thiazolidinediones | GLP-1R Agonist

Data type

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2,1]
C0378073
UMLS CUI [2,2]
C2987634
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01733758

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Antidiabetics Oral Quantity | Antidiabetics Dose Stable
Item
subjects with diagnosis of type 2 diabetes mellitus, treated with diet and exercise or a stable dose of 1 oad at screening
boolean
C0011860 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
C0935929 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
C0935929 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
Body mass index
Item
body mass index (bmi) 17 to 40 kg/ m^2 inclusive
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Oral Absent | Hemoglobin A1c measurement | Antidiabetics Oral Quantity
Item
subjects who are oad naïve, hba1c between 7.0% and 10.0% at screening and at visit 2; for subjects who enter the study with 1 oad, hba1c between 6.5% and 9.5% at screening and hba1c between 7.0% and 10.0% at visit 2
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0474680 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine clearance >30 ml/min (calculated using the cockcroft-gault formula)
boolean
C2711451 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Pregnancy | Breast Feeding | Postpartum Period
Item
history of type 1 diabetes mellitus •female subject is pregnant, lactating, or <6 weeks postpartum•
boolean
C0011854 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0086839 (UMLS CUI [4])
Cardiovascular Disease | Cerebrovascular Disorder
Item
clinically significant cardiovascular and/or cerebrovascular disease
boolean
C0007222 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
Gall Bladder Disease Symptomatic | Sign or Symptom Pancreatitis | Pancreatitis, Chronic | Pancreatitis
Item
current ongoing symptomatic biliary disease, clinical signs or symptoms of pancreatitis, or a history of chronic or acute pancreatitis, as determined by the investigator
boolean
C0016977 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C3540840 (UMLS CUI [2,1])
C0030305 (UMLS CUI [2,2])
C0149521 (UMLS CUI [3])
C0030305 (UMLS CUI [4])
Serum amylase raised | Serum lipase raised | Symptoms Relationship Pancreatitis
Item
serum amylase >=3 ×uln and/or serum lipase >=2 × uln and/or subject is experiencing any symptoms possibly related to pancreatitis
boolean
C0476327 (UMLS CUI [1])
C3670924 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0030305 (UMLS CUI [3,3])
Thiazolidinediones | GLP-1R Agonist
Item
prior use of a tzd or glp-1r agonist within 4 months before screening
boolean
C1257987 (UMLS CUI [1])
C0378073 (UMLS CUI [2,1])
C2987634 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial